Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium

Future Oncol. 2016;12(8):1005-8. doi: 10.2217/fon-2016-0021. Epub 2016 Feb 9.

Abstract

38th San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 8-12 December 2015. In November 1978, during Breast Cancer Awareness Week, the first annual San Antonio Breast Cancer Symposium (SABCS) was held as a part of an educational program conceived to reduce breast cancer death rate. Only 141 physicians attended the conference. Recently, the 38th edition of the SABCS welcomed >7000 attendees from all over the world. We will discuss a selection of the most significant advances presented at the 2015 SABCS, specifically focusing on those data that could have an impact on the clinical practice in the near future.

Keywords: 38th SABCS; breast cancer; clinical research; translational research.

Publication types

  • Congress

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor
  • Biomedical Research
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / etiology
  • Breast Neoplasms / mortality
  • Breast Neoplasms / therapy*
  • Carboplatin / administration & dosage
  • Carboplatin / therapeutic use
  • Female
  • Humans
  • Neoplastic Cells, Circulating
  • Prognosis
  • Receptor, ErbB-2
  • Translational Research, Biomedical
  • Triple Negative Breast Neoplasms / drug therapy

Substances

  • Biomarkers, Tumor
  • Carboplatin
  • Receptor, ErbB-2